Trastuzumab (high-dose)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Trastuzumab (high-dose), covering 2020-03-27 to 2020-03-27. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Pertuzumab With High-Dose Trastuzumab for the Treatment of Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer (MBC) With Central Nervous System (CNS) Progression Post-Radiotherapy [Phase 2]